{"id":"W1986691999","doi":"10.1016/s1098-3015(10)70208-4","title":"PCN30 COSTS RELATED TO ADVERSE EVENTS IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS IN CANADA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Myeloid leukemia; Tyrosine kinase; Medicine; Adverse effect; Tyrosine-kinase inhibitor; Oncology; Internal medicine; Cancer research; Pharmacology; Cancer; Receptor","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003033501,0.0004195849,0.0008075496,0.0006378079,0.00007700388,0.000001634072,0.0001454222,0.0001536137,0.00005042104],"category_scores_gemma":[0.0001439226,0.0003813819,0.00004599843,0.001924686,0.00004596867,0.0001193502,0.00006017088,0.0006303886,0.00004553448],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.1468351,"about_ca_system_score_gemma":0.02731604,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9804895,"about_ca_topic_score_gemma":0.9110663,"domain_scores_codex":[0.9960906,0.0002814711,0.001141625,0.0007168436,0.0007097563,0.001059698],"domain_scores_gemma":[0.9984458,0.0001127074,0.0002371031,0.0005430042,0.00007590966,0.0005854678],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006167021,0.0003270335,0.9779118,0.0001556048,0.00002407663,0.001126051,0.0006887994,0.01624473,0.00004327324,0.000004899247,0.0003751081,0.002481915],"study_design_scores_gemma":[0.02253298,0.001375558,0.9695359,0.002952178,0.00001208118,0.0000657284,0.0001138408,0.002373558,0.0003846324,0.000002785671,0.0003392024,0.0003115185],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958751,0.0005820914,3.594662e-7,0.0004786343,0.0001803011,0.002584946,0.00003497724,0.00004426573,0.0002193911],"genre_scores_gemma":[0.9982257,0.0003566355,0.0001340108,0.0005546146,0.00003491497,0.0001335739,0.0002267277,0.0000749877,0.0002588756],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1195191,"threshold_uncertainty_score":0.9998638,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01433573690087555,"score_gpt":0.2454023561715701,"score_spread":0.2310666192706946,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}